RALEIGH, N.C., Aug. 23 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will exhibit our cardiology expertise and experience at the European Society of Cardiology's (ESC) annual conference in Stockholm, Sweden from 28 August to 1 September 2010.
At PRA booth C18:62, attendees can schedule meetings with our leading expert in cardiovascular (CV) disease, Dr. Michael Kirchengast, Vice President and Head of Scientific Affairs at PRA, to learn how PRA can support drug development projects.
In addition to his ESC attendance, Dr. Kirchengast is also hosting a CV audio conference on 24 August 2010 at 11:30 am (EDT). Those wishing to attend this session can learn key concepts and explore new strategies for preventing some of the expensive failures that pharmaceutical companies experience during late-stage development.
Dr. Kirchengast has 30 years of experience in CV research and development, including interactions with multiple authorities. His wide range of development experience encompasses antiarrhythmics, antithrombotics, antihypertensives, antihyperlipidemics, heart failure therapeutics, and vascularly active and cardioprotective drugs.
Additional PRA representatives, including Dr. Margit Banagl, Executive Director of Medical Affairs, will be at ESC to provide information on the full breadth of PRA's services.
For more information about our ESC exhibit and Dr. Kirchengast's audio conference, navigate to www.praintl.com and click on "Events." To register for the audio conference, email firstname.lastname@example.org.
About PRA International
PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology/Hematology